Company Appoints Seasoned Medtech Executive as President and CEO CAMPBELL, Calif., March 5, 2020 /PRNewswire/ — Supira Medical, formed by Shifamed as part of its medical innovation hub, announced today the closing of $35M in Series B financing. Officially closed on February 25, the financing was led by Cormorant Asset Management with participation from The Capital […]
Financial
Ra Medical Systems Announces NYSE Acceptance of Compliance Plan
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announces that the New York Stock Exchange (the “NYSE”) has accepted the Company’s business plan to regain compliance with the NYSE continued listing standards. “We are […]
Miami Cardiac & Vascular Institute Names Joseph T. McGinn, Jr., M.D., chief of Cardiac Surgery
MIAMI, March 4, 2020 /PRNewswire-HISPANIC PR WIRE/ — Miami Cardiac & Vascular Institute, part of Baptist Health and the region’s largest and most comprehensive cardiovascular facility, has named Joseph T. McGinn, Jr., M.D., chief of Cardiac Surgery. Dr. McGinn specializes in the assessment and surgical treatment of patients with coronary artery, aortic and […]
CORRECTING and REPLACING – Microbot Medical Appoints Eyal Morag M.D. as Chief Medical Officer
HINGHAM, Mass., March 03, 2020 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Microbot Medical Inc. (NASDAQ: MBOT), please note that in the first paragraph the appointment of Eyal Morag, M.D. has been changed to commencing June 2020 and in the fourth paragraph Dr. Morag still currently […]
Orchestra BioMed™ Adds Seasoned Biotech Executive Pamela Yanchik Connealy to Board of Directors
Ms. Yanchik Connealy will serve as the Audit Committee Chair, strengthening Orchestra BioMed’s financial reporting capabilities NEW HOPE, Pa., March 03, 2020 (GLOBE NEWSWIRE) — Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company providing high-impact solutions for large unmet needs in procedure-based medicine, today announced the […]
CHF Solutions, Inc. Announces Fourth Quarter Financial Results and Provides Company Update
EDEN PRAIRIE, Minn., March 03, 2020 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the fourth quarter and year ended December 31, 2019, which included the following highlights: Received 510(k) clearance in the U.S. and CE Mark in the EU for adult and pediatric patients […]
Eko Named to the 2020 CB Insights AI 100 List of Most Innovative Artificial Intelligence Startups
Eko honored for achievements in AI-powered solutions to improve cardiac care BERKELEY, Calif.–(BUSINESS WIRE)–Eko today announced that it has been named to CB Insights’ fourth annual AI 100 ranking, showcasing the 100 most promising private artificial intelligence companies in the world. “Eko has achieved numerous milestones over the past year, including partnerships with […]
Element Science Raises $145.6 million Series C Financing to Advance Next-Generation Digital Wearable Platform
Newcomers Deerfield, Qiming, Cormorant, and Invus join existing investors Third Rock and Google Ventures; Funding will enable Element Science to complete clinical studies, begin commercialization and develop a family of products SAN FRANCISCO–(BUSINESS WIRE)–Element Science, an innovative health technology company pioneering a next-generation digital wearable platform focused on high-risk cardiovascular […]
AliveCor Appoints Siva Somayajula as Chief Technology Officer
Former Amazon Director of Product Software and Services Brings Deep Expertise in Technology and Product Innovation MOUNTAIN VIEW, Calif., March 2, 2020 /PRNewswire/ — AliveCor, the leader in AI-based, personal ECG technology, and provider of enterprise cardiology solutions, today announced the appointment of Siva Somayajula, as its Chief Technology Officer. For more than […]
Correvio Responds to Market Activity
VANCOUVER, March 2, 2020 /PRNewswire/ – At the request of Investment Industry Regulatory Organization of Canada (“IIROC”), Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV) (the “Company”) wishes to confirm that it is not aware of any material, undisclosed information related to the Company that would account for the recent increase in the market price and level […]



